Anidulafungin Accord 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
7680683570019
CH-68357
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Associated product:
ANIDULAFUNGIN Accord subst sèche 100 mg flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
100.0 MG | Substance | HBESI |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 381.95
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/12/2022
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 68357
- Drug name
- Anidulafungin Accord, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- J02AX06
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 18/11/2021
- Authorization expiration date
- 17/11/2026
- IT Number
- 08.06.0.
- Domain
- Human medicine
Package details
- Description (FR)
- ANIDULAFUNGIN Accord subst sèche 100 mg flac
- Description (DE)
- ANIDULAFUNGIN Accord Trockensub 100 mg Durchstf
- Market launch
- 18/11/2021
- Narcotic (BTM)
- No
Original drug
Ecalta, Pulver zur Herstellung einer Infusionslösung
GTIN: 7680583250035
CHF 442.80